Home / Treatments / Synvisc One Injection
Synvisc One Injection denials: what the review data shows
Independent reviewers have decided 51 published cases where an insurer denied Synvisc One Injection — and they overturned the insurer 80.4% of the time. A denial for Synvisc One Injection is a starting position, not a final answer.
Published decisions
51
2001–2026
Overturned
80.4%
41 denials reversed
By condition
Published outcomes when Synvisc One Injection was denied for these conditions.
| Condition | Decisions | Overturned |
|---|---|---|
| Osteoarthritis | 29 | 93.1% |
| Osteoarthritis | 28 | 92.9% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Synvisc One Injectionwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.